Format

Send to

Choose Destination
See comment in PubMed Commons below
Gastroenterol Hepatol (N Y). 2010 Jan;6(1):39-44.

Probiotic therapy for irritable bowel syndrome.

Author information

1
Drs. Aragon and Graham are Gastroenterology Fellows at the George Washington University School of Medicine in Washington, DC.

Abstract

The etiology of irritable bowel syndrome (IBS) is thought to be multifactorial, with several factors (including alterations in gut motility, small-bowel bacterial overgrowth, microscopic inflammation, and visceral hypersensitivity) potentially playing a role. Recent studies have suggested that probiotics may be useful in the treatment of IBS. Although the exact mechanism for how probiotics may aid in the reduction of symptoms commonly found in IBS is unknown, the effects of probiotics on alterations in gut bacteria appear to play a part. This review focuses on recent studies examining the role of probiotics in the treatment of IBS.

KEYWORDS:

Irritable bowel syndrome; probiotics; small-bowel bacterial overgrowth

PMID:
20567539
PMCID:
PMC2886445
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center